FFCP PHASE1:Hg19::chr8:54090128..54090133,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene= | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=gencodeV16_ncRNA | |||
|HGNC= | |||
|TSSclassifier=strong | |||
|UniProt= | |||
|association_with_transcript=0bp_to_ENST00000529837_5end | |||
|cluster_id=chr8:54090128..54090133,+ | |||
|coexpression_cluster_id=C400 | |||
|description=CAGE_peak_1_at_ENST00000529837_5end | |||
|id=chr8:54090128..54090133,+ | |||
|ontology_enrichment_celltype=CL:0000763!5.81e-09!112;CL:0000049!5.81e-09!112;CL:0000037!6.19e-08!172;CL:0000566!6.19e-08!172;CL:0000784!1.26e-07!3;CL:0002032!1.80e-07!165;CL:0000837!1.80e-07!165;CL:0000988!2.94e-07!182 | |||
|ontology_enrichment_celltype_v019=CL:0002178;7.92e-07;3 | |||
|ontology_enrichment_celltype_v019_2=CL:0002178,7.28e-07,3 | |||
|ontology_enrichment_development_v019=UBERON:0009117;1.65e-07;10!UBERON:0005564;1.65e-07;10 | |||
|ontology_enrichment_disease=DOID:1240!5.28e-29!39;DOID:8692!1.64e-24!31;DOID:2531!2.50e-21!51;DOID:0060083!2.50e-21!51;DOID:0050686!4.35e-11!137;DOID:162!2.43e-08!235;DOID:14566!4.72e-08!239;DOID:225!9.91e-07!1 | |||
|ontology_enrichment_disease_v019=DOID:225;2.66e-18;1!DOID:74;7.98e-10;2!DOID:3493;1.27e-09;2!DOID:3910;1.86e-09;2!DOID:1036;3.01e-09;8!DOID:1240;1.08e-08;39!DOID:8692;3.68e-08;31 | |||
|ontology_enrichment_disease_v019_2=DOID:225,2.66e-18,1;DOID:1240,9.43e-11,39;DOID:74,7.98e-10,2;DOID:3493,1.12e-09,2;DOID:3910,2.02e-09,2;DOID:1036,3.27e-09,8;DOID:8692,5.83e-09,31;DOID:2531,3.19e-08,51;DOID:0060083,3.19e-08,51 | |||
|ontology_enrichment_uberon= | |||
|ontology_enrichment_uberon_v019=UBERON:0004903;1.86e-09;2!UBERON:0002173;1.86e-09;2!UBERON:0002186;1.86e-09;2!UBERON:0000473;3.62e-09;8!UBERON:0003135;6.64e-07;11 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0004903,2.02e-09,2;UBERON:0002173,2.02e-09,2;UBERON:0002186,2.02e-09,2;UBERON:0000473,3.41e-09,8;UBERON:0003135,6.35e-07,11 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.383829398097213,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.212604299965044,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.785874452986276,0,0,0,0,0,0.238490624305342,0.571994910780128,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0974370051611986,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.10833939483032,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0711418433484141,0.159426272728822,0,0,0,27.2682429830627,50.5434920604226,0.228234679033192,0.156679895773023,0,0.338583555603207,0,0,0,0,0.307240764308458,0.223676107892416,0.500547425135725,0.19538809540204,0,0,28.9387575969302,0.66614393599564,0,0.37428108081644,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.01701460117107,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.06579894587209,3.29658538429552,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.067401132980677,0,0.234264445725339,0,0,0,0,0,1.22429104652196,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0787831823072236,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.082092520749339,0,0,0,0,0,0,0.171086837884329,0,0,0,0,0,0,0,0,0,0,0,0,0.314108192500469,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.214441591374926,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,51.8521806313525,0,0,0,0,0,0.127894371303652,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.175871244359621,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.173858272302579,0,0,0,0,0,0,0,0,0,0,0,0,3.92600934460972,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.28823786971007,3.48353369203032,0,0,0,0,0.0645889098360061,0.186224142887574,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p1@ENST00000529837 | |||
}} |
Latest revision as of 18:51, 31 July 2015
Short description: | p1@ENST00000529837 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_1_at_ENST00000529837_5end |
Coexpression cluster: | C400_acute_leukemia_chronic_myelodysplastic_NK_pancreas_duodenum |
Association with transcript: | 0bp_to_ENST00000529837_5end |
EntrezGene: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
epithelial cell of stomach | 7.28e-07 | 3 |
Ontology term | p-value | n |
---|---|---|
bronchoalveolar duct junction | 2.02e-09 | 2 |
alveolar duct | 2.02e-09 | 2 |
bronchiole | 2.02e-09 | 2 |
testis | 3.41e-09 | 8 |
male reproductive organ | 6.35e-07 | 11 |
Ontology term | p-value | n |
---|---|---|
syndrome | 2.66e-18 | 1 |
leukemia | 9.43e-11 | 39 |
hematopoietic system disease | 7.98e-10 | 2 |
signet ring cell adenocarcinoma | 1.12e-09 | 2 |
lung adenocarcinoma | 2.02e-09 | 2 |
chronic leukemia | 3.27e-09 | 8 |
myeloid leukemia | 5.83e-09 | 31 |
hematologic cancer | 3.19e-08 | 51 |
immune system cancer | 3.19e-08 | 51 |